Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
33 studies found for:    " February 18, 2013":" March 20, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting
Has Results
Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants
Conditions: HIV;   HIV Infections
Interventions: Drug: E/C/F/TAF;   Drug: E/C/F/TDF;   Drug: EFV/FTC/TDF;   Drug: RTV;   Drug: ATV;   Drug: FTC/TDF;   Drug: COBI
2 Completed Antiretroviral Therapy and Extreme Weight
Condition: HIV Infection
Intervention:
3 Active, not recruiting
Has Results
Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: E/C/F/TAF;   Drug: E/C/F/TDF;   Drug: E/C/F/TDF Placebo;   Drug: E/C/F/TAF Placebo
4 Completed Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine
Condition: HIV Seropositivity
Intervention:
5 Recruiting Trial of Vitamin D in HIV Progression
Condition: HIV Infection
Interventions: Dietary Supplement: Vitamin D3 (cholecalciferol);   Other: Placebo
6 Terminated
Has Results
A Trial Examining the Efficacy of Escitalopram Oxalate Upon Depressive Symptoms and Fatigue in HIV Seropositive Women
Conditions: Depression;   HIV
Interventions: Drug: Placebo;   Drug: Escitalopram
7 Completed Evaluating the Safety and Priming Response of an HIV Vaccine Regimen in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123;   Biological: NYVAC-HIV-PT1;   Biological: NYVAC-HIV-PT4;   Biological: AIDSVAX® B/E;   Biological: Placebo for DNA/NYVAC;   Biological: Placebo for AIDSVAX(R) B/E
8 Enrolling by invitation The "START" (a Streamlined ART Initiation Strategy) Study
Condition: HIV
Intervention: Behavioral: START
9 Recruiting Intervention Research to Reduce HIV Sexual Transmission Among HIV Positive Men Who Have Sex With Men
Condition: HIV
Interventions: Behavioral: Gay Poz Sex;   Other: Wait List/Standard of Care
10 Active, not recruiting Immune Enhancement for Immunological Non-responders to ART
Condition: HIV
Intervention: Dietary Supplement: Zinc and SAMe
11 Recruiting HIV Test and Treat to Prevent HIV Transmission Among MSM and Transgender Women
Condition: HIV
Intervention: Drug: Atripla or Stribild
12 Completed Optimizing Integrated PMTCT Services in Rural North-Central Nigeria
Conditions: Suspected Damage to Fetus From Viral Disease in the Mother;   HIV
Interventions: Other: Task-shifting to lower-cadre providers at PMTCT sites;   Other: POC CD4+ cell count testing;   Other: integrated mother-infant care;   Other: Prominent role for influential family members (male partners) in collaboration with CHWs
13 Unknown  Alcohol Use and Risky Sexual Behaviors Among HIV Infected Subjects in Kampala Uganda
Conditions: Alcohol Use;   HIV
Intervention: Behavioral: Motivational intervention counselling plus SPP
14 Completed National Evaluation of PI-based 2nd Line Efficacy in Cambodia
Condition: HIV
Intervention:
15 Unknown  Social Networks and Prevention
Condition: HIV
Interventions: Behavioral: SNAP;   Behavioral: SNAP Control
16 Unknown  Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders
Condition: HIV
Interventions: Drug: Triptolide;   Drug: cART;   Drug: placebo
17 Terminated
Has Results
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Condition: Human Immunodeficiency Virus
Intervention:
18 Completed HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)
Condition: HIV
Intervention: Drug: FTC/TDF
19 Completed Pharmacokinetics of Tenofovir and Tenofovir-diphosphate, Emtricitabine and Emtricitabine-triphosphate, and Rilpivirine Once Daily Over 14 Days Following Drug Intake Cessation in Healthy Volunteers
Condition: HIV
Intervention: Drug: Eviplera®
20 Completed Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB
Condition: HIV/TB Co-infection
Interventions: Drug: Nevirapine;   Drug: Efavirenz

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.